For pharma, diagnosing what ails or strengthens performance in this critical corporate discipline may help reshape business prognosis.
Richard M. Bayney
Advertisement
Articles by Richard M. Bayney
Advertisement
Latest Updated Articles
Portfolio Management Health CheckMay 12th 2017
Advertisement
Advertisement
Trending on PharmExec
1
What Pharma Marketers Need to Know About Recent Gartner Predictions About AI and What It Means to Them
2
What Governance Resets Should Pharma Companies Take in Response to AI?
3
FDA Approves Icotyde as Treatment of Moderate-to-Severe Plaque Psoriasis in Adults and Adolescents
4
TrumpRx Selling Medicines at Higher Prices Than Other Countries: Report
5